Phaseline

Targets › RNA

RNA: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Infectious disease; next expected readout Nov 2026.

Open in Phaseline: the race on RNA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Ain Shams UniversityClarithromycin
Bacterial 70S ribosome inhibitor
RNAPhase 2Helicobacter Pylori InfectionNov 2026

Conditions

Helicobacter Pylori Infection (1)

Modalities

small molecule (1)

Companies

Ain Shams University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.